DR. JOHN T STRONY, M.D.
Osteopathic Medicine in Kenilworth, NJ
License number
New Jersey 25MA07016800
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
2015 Galloping Hill Rd K15-3, Kenilworth, NJ 07033
14 Cheshire Ct, Lebanon, NJ 08833
14 Cheshire Ct, Lebanon, NJ 08833
Phone
(908) 740-2125
(908) 713-6267 (Fax)
(908) 713-6267 (Fax)
Professional information
Dr. John T Strony, Rahway NJ - MD (Doctor of Medicine)
Specialties:
Cardiology, Interventional Cardiology
Address:
126 E Lincoln Ave, Rahway 07065
SCHERING-PLOUGH RESEARCH INST.
2015 Galloping Hill Rd, Kenilworth 07033
(908) 740-2407 (Phone), (908) 740-2145 (Fax)
2000 Galloping Hill Rd, Kenilworth 07033
(908) 298-4000 (Phone), (973) 235-7409 (Fax)
SCHERING-PLOUGH RESEARCH INST.
2015 Galloping Hill Rd, Kenilworth 07033
(908) 740-2407 (Phone), (908) 740-2145 (Fax)
2000 Galloping Hill Rd, Kenilworth 07033
(908) 298-4000 (Phone), (973) 235-7409 (Fax)
Certifications:
Cardiovascular Disease, 1989, Internal Medicine, 1983, Interventional Cardiology, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Temple University
Graduated: 1980
Med Coll Penn
University Of Minnesota
Temple University
Graduated: 1980
Med Coll Penn
University Of Minnesota
Thrombin Receptor Antagonists As Prophylaxis To Complications From Cardiopulmonary Surgery
US Patent:
2009006, Mar 5, 2009
Filed:
Oct 30, 2008
Appl. No.:
12/261844
Inventors:
Enrico P. Veltri - Princeton NJ, US
John T. Strony - Lebanon NJ, US
Gail Berman - Westfield NJ, US
John T. Strony - Lebanon NJ, US
Gail Berman - Westfield NJ, US
International Classification:
A61K 31/443, A61P 9/00, A61K 31/444, A61K 31/60, A61K 31/4365
US Classification:
514161, 514337, 514333, 514301
Abstract:
Disclosed herein are methods of preventing, inhibiting, or ameliorating complications associated with cardiopulmonary bypass surgery by the use of a thrombin receptor antagonist compound. Among the thrombin receptor antagonist compounds useful in these methods are those of Formulas I and II, described herein. Examples of such thrombin receptor antagonists include:
Combinations Of Sterol Absorption Inhibitor(S) With Cardiovascular Agent(S) For The Treatment Of Vascular Conditions
US Patent:
2003006, Apr 10, 2003
Filed:
Jan 25, 2002
Appl. No.:
10/057339
Inventors:
Teddy Kosoglou - Jamison PA, US
Rudyard Ress - Flemington NJ, US
John Strony - Lebanon NJ, US
Enrico Veltri - Princeton NJ, US
William Hauer - Warren NJ, US
Rudyard Ress - Flemington NJ, US
John Strony - Lebanon NJ, US
Enrico Veltri - Princeton NJ, US
William Hauer - Warren NJ, US
Assignee:
Schering Corporation
International Classification:
A61K031/397
US Classification:
514/210020
Abstract:
The present invention provides compositions, therapeutic combinations and methods including: (a) at least one sterol absorption inhibitor and (b) at least one cardiovascular agent different from the sterol absorption inhibitor, which can be useful for treating vascular conditions, obesity, diabetes and lowering plasma levels of sterols.
Reduction Of Adverse Events After Percutaneous Intervention By Use Of A Thrombin Receptor Antagonist
US Patent:
2008023, Sep 25, 2008
Filed:
Mar 19, 2008
Appl. No.:
12/051504
Inventors:
Enrico P. Veltri - Princeton NJ, US
John T. Strony - Lebanon NJ, US
Madhu Chintala - Colts Neck NJ, US
John T. Strony - Lebanon NJ, US
Madhu Chintala - Colts Neck NJ, US
International Classification:
A61K 31/443, A61K 31/5377, A61K 31/4365, A61K 31/60
US Classification:
514165, 514337, 5142328, 514301
Abstract:
Disclosed are methods of preventing adverse clinical events in a patient undergoing a percutaneous coronary intervention procedure or a peripheral percutaneous interventional procedure comprising administering a therapeutically effective amount of a thrombin receptor antagonist, such as SCH 530348, to the patient. Administration of a loading dose of about 40 mg of SCH 530348 in as little as one hour prior to the procedure can result in therapeutically effective levels of platelet aggregation.
"The Use Of A Par-1 Antagonist In Combination With A P2Y12 Adp Receptor Antagonist For Inhibition Of Thrombosis"
US Patent:
2012018, Jul 19, 2012
Filed:
Sep 24, 2010
Appl. No.:
13/498742
Inventors:
John T. Strony - Lebanon NJ, US
Madhu Chintala - Colts Neck NJ, US
Madhu Chintala - Colts Neck NJ, US
International Classification:
A61K 31/7076, A61K 31/519, A61K 31/517, A61P 9/10, A61P 9/00, A61K 31/443, A61K 31/444, A61P 7/02, A61K 31/4365, A61K 31/5377
US Classification:
514 47, 514301, 5142611, 51426624, 5142352
Abstract:
The treatment and prevention of thrombotic events are provided through co-administration of PAR-1 and the P2Y12 ADP receptor antagonists. Combined inhibition of the PAR-1 and the P2Y12 ADP platelet activation pathways had synergistic antithrombotic and antiplatelet effects, as demonstrated in co-administration of SCH 602539 and cangrelor.
Combinations Of Hormone Replacement Therapy Composition(S) And Sterol Absorption Inhibitor(S) And Treatments For Vascular Conditions In Post-Menopausal Women
US Patent:
7056906, Jun 6, 2006
Filed:
Sep 19, 2002
Appl. No.:
10/247085
Inventors:
John T. Strony - Lebanon NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31/00, A61K 31/56, A61K 31/7028, A61K 31/397
US Classification:
51421002, 23 25, 23170, 536 174
Abstract:
The present invention provides compositions, therapeutic combinations and methods including: (a) at least one hormone replacement therapy composition; and (b) at least one sterol absorption inhibitor which can be useful for treating vascular conditions in post-menopausal women and lowering plasma levels of sterols or 5α-stanols.
Methods And Therapeutic Combinations For The Treatment Of Diabetes Using Sterol Absorption Inhibitors
US Patent:
7071181, Jul 4, 2006
Filed:
Sep 19, 2002
Appl. No.:
10/247099
Inventors:
Harry R. Davis - Berkeley Heights NJ, US
Teddy Kosoglou - Jamison PA, US
Gilles J. Picard - Braine L'Alleud, BE
Rudyard J. Ress - Flemington NJ, US
John T. Strony - Lebanon NJ, US
Enrico P. Veltri - Princeton NJ, US
Teddy Kosoglou - Jamison PA, US
Gilles J. Picard - Braine L'Alleud, BE
Rudyard J. Ress - Flemington NJ, US
John T. Strony - Lebanon NJ, US
Enrico P. Veltri - Princeton NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31/397, A61K 31/7052
US Classification:
51421002, 514 23, 514 25, 536 174
Abstract:
The present invention provides methods of treating diabetes and associated conditions by administering a composition including at least one sterol or 5α-stanol absorption inhibitor or compositions or therapeutic combinations including: (a) at least one antidiabetic medication; and (b) at least one sterol or 5α-stanol absorption inhibitor.
Combinations Of Sterol Absorption Inhibitor(S) With Blood Modifier(S) For Treating Vascular Conditions
US Patent:
2002014, Oct 10, 2002
Filed:
Jan 25, 2002
Appl. No.:
10/056680
Inventors:
Teddy Kosoglou - Jamison PA, US
Rudyard Ress - Flemington NJ, US
John Strony - Lebanon NJ, US
Enrico Veltri - Princeton NJ, US
Rudyard Ress - Flemington NJ, US
John Strony - Lebanon NJ, US
Enrico Veltri - Princeton NJ, US
Assignee:
Schering Corporation
International Classification:
A61K031/397
US Classification:
514/210020
Abstract:
The present invention provides compositions, therapeutic combinations and methods including: (a) at least one sterol absorption inhibitor; and (b) at least one blood modifier, which can be useful for treating vascular conditions and lowering plasma levels of sterols.
Methods And Therapeutic Combinations For The Treatment Of Obesity Using Sterol Absorption Inhibitors
US Patent:
2003011, Jun 26, 2003
Filed:
Sep 19, 2002
Appl. No.:
10/247397
Inventors:
Harry Davis - Berkeley Heights NJ, US
Rudyard Ress - Flemington NJ, US
John Strony - Lebanon NJ, US
Enrico Veltri - Princeton NJ, US
Rudyard Ress - Flemington NJ, US
John Strony - Lebanon NJ, US
Enrico Veltri - Princeton NJ, US
Assignee:
Schering Corporation
International Classification:
B24B001/00
US Classification:
451/059000
Abstract:
The present invention provides methods for the treatment of obesity using sterol or 5-stanol absorption inhibitors and compositions and therapeutic combinations including sterol or 5-stanol absorption inhibitors and at least one obesity control medication.
Methods And Therapeutic Combinations For The Treatment Of Obesity Using Sterol Absorption Inhibitors
US Patent:
2006000, Jan 12, 2006
Filed:
Aug 31, 2005
Appl. No.:
11/216515
Inventors:
Harry Davis - Berkeley Heights NJ, US
Rudyard Ress - Flemington NJ, US
John Strony - Lebanon NJ, US
Enrico Veltri - Princeton NJ, US
Rudyard Ress - Flemington NJ, US
John Strony - Lebanon NJ, US
Enrico Veltri - Princeton NJ, US
International Classification:
A61K 31/7052, A61K 31/397
US Classification:
514023000, 514210020
Abstract:
The present invention provides methods for the treatment of obesity using sterol or 5α-stanol absorption inhibitors and compositions and therapeutic combinations including sterol or 5α-stanol absorption inhibitors and at least one obesity control medication.